AzTrials
AzTrials

High Risk of FallingPCRetroNCT07650097

Backward Walking Rehabilitation to Prevent Falls in High-risk Adults Aged 75 Years and Older

A study testing Walking backwards and Usual walking in people with High Risk of Falling, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Falls are a major health problem for people aged 75 or older. Backward walking may strengthen the muscles of the legs, improve posture and balance, and make walking more stable, which could help prevent new falls and improve everyday movement. Read more about this study

Who is it for?
Ages 75 years and older
Conditions the study is for
High Risk of Falling
What is being tested?
Walking backwards and Usual walking
Could I receive a placebo?
No, everyone receives an active treatment
How many people
300 participants
Where
1 siteFrance
Study dates
15 Nov 2026to 15 May 2029
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 75 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • People aged 75 or older
  • Consultant at a geriatric day hospital
  • At high risk of falling. High risk of falling is defined in accordance with the World guidelines for falls prevention and management for older adults: a global initiative. The patient must have at least one of the following characteristics:
  • At least two falls in the last 12 months;
  • A fall resulting in an injury requiring medical attention;
  • Inability to get up unaided after a fall for at least one hour;
Show all 12Show fewer
  • Suspected syncope;
  • Frailty (Clinical Frailty Scale ≥4)
  • Able to walk on a treadmill (physically able and capable of understanding the physiotherapist's instructions)
  • Able to understand and follow instructions from healthcare professionals
  • Patient or guardian who has been informed about the study and has given their free, informed and written consent to participate
  • Covered by a social security scheme (member or beneficiary) excluding Aide Médicale d'Etat (AME).

Who cannot join

  • Acute medical condition incompatible with prolonged standing (at the inclusion visit)
  • Estimated life expectancy of less than one year (at the inclusion visit)
  • Participation in another interventional trial or being within the exclusion period following a previous trial, where applicable (at the inclusion visit)
  • Balance disorders related to vestibular and cerebellar disorders (at the inclusion visit).

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Bruno OQUENDO, Dr contact

01 49 59 43 53

bruno.oquendo@aphp.fr

France1 site
  • Hôpital Charles-Foix

    Ivry-sur-Seine, 94205

    Bruno OQUENDO, Dr, 01 49 59 43 53, bruno.oquendo@aphp.fr

Other trials in France

About this study

Official title: Preventing Falls in People Aged 75 or Older at High Risk of Falling Through Specific Rehabilitation Involving Walking Backwards

Falls are a major health problem for people aged 75 or older. Backward walking may strengthen the muscles of the legs, improve posture and balance, and make walking more stable, which could help prevent new falls and improve everyday movement.

This is an open-label, multicenter, randomized controlled trial that will examine whether backward walking, integrated to usual rehabilitation in a geriatric day hospital program, can help reduce the number of new falls in older adult at high risk of falling.

Read more

About 300 people aged 75 years or older, living at home and at high risk of falling, will be included in this trial in 11 geriatric day hospitals in France. After receiving appropriate information, those who agree to participate will sign a written consent form and will then be randomly assigned to one of two groups. Both groups will receive standard rehabilitation care in the geriatric day hospital, with two rehabilitation sessions per week for 12 weeks. In the control group, patients will only receive usual care to prevent falls previously described above. In the intervention group, part of the usual care will be replaced, for 5 weeks, by supervised backward walking exercises, with the goal of doing two effective 10 minute backward walking sessions per week, without increasing the total time spent in rehabilitation.

The trial will be conducted under the intention-to-treat principle. Participants will have a clinical visit at day 0, at week 5 and at 6 months, during which clinical information and data related to their usual care and to the study will be collected. All participants will be followed for a total of 12 months, with monthly phone calls from a study team member to record any new falls, hospitalizations, health problems, or other important events. For 10 patients in the intervention group, an individual interview will also be carried out at the 5 week visit to better understand their experience of backward walking. 2 focus groups will be held with 2 randomly selected centers to identify barriers and facilitators to the implementation of backward walking sessions.

This study aims to determine whether adding backward walking to standard rehabilitation is a safe, acceptable and effective way to prevent falls in older adults at high risk of falling.

Read the detailed description

Justification: Falls are the leading cause of unintentional injuries in the population aged 75 or older in France. Backward walking training has so far been scarcely studied but appears to show promising results compared with conventional rehabilitation across multiple domains. It improves functional capacity, lower limb muscle strength, gait parameters, balance, and stability, all of which are key factors in reducing fall risk. Therefore, we hypothesize that a post-fall rehabilitation program incorporating backward walking sessions may reduce the incidence of falls over one year in high fall risk patients aged 75 or older, compared with a standard rehabilitation program.

Primary objective: The primary objective of the study is to assess the impact of backward walking sessions on the incidence of falls at 1 year in patients aged 75 or older at high risk of falling and managed in a geriatric day hospital, compared with usual care in a geriatric day hospital.

Secondary objectives: The secondary objectives are to assess the effects of backward walking intervention, compared with usual care, on physical and psychological performance as balance, gait speed, functional mobility, fear of falling, and on the occurrence of falls and serious events (time to first fall, all-cause and fall-related hospitalizations, mortality). It also aims to evaluate medium- and long-term quality of life, functional independence, and all-cause hospitalizations, as well as the safety, acceptability, and feasibility of the intervention for patients and the day hospital team.

Settings: The sample size calculation was performed to detect a 35% reduction in the annual incidence rate of falls, assuming a control-group incidence of 1.4-3.6 falls per person-year and accounting for an anticipated 10% loss to follow-up. A total of 300 patients are expected to be enrolled over an 18 month inclusion period, with each patient followed for 12 months. Eleven geriatric centers will participate in the trial.

Experimental design: The PCRetro trial is an open-label, multicenter, randomized controlled, parallel-group clinical trial conducted in a geriatric day hospital rehabilitation setting. The study procedures are as follows: during the geriatric day hospital visit, the investigator will propose participation in the trial to eligible patients after verifying inclusion and exclusion criteria, and will subsequently obtain written informed consent. Patients will then be randomized to the control or intervention arm. Patients in the control arm will undergo two rehabilitation sessions per week for 12 weeks according to usual care. Patients in the intervention arm will undergo two rehabilitation sessions per week for 12 weeks according to usual care, combined with backward walking sessions over 5 weeks. In the intervention arm, backward walking will not increase the overall rehabilitation time but will replace part of usual care in order to achieve two effective 10-minute backward walking sessions per week. Patients will be followed in the same way regardless of their randomization arm, with a medical visit at week 5 and at month 6, and a monthly telephone call by a clinical research assistant blinded to the randomization allocation.

Practical procedures: A screening visit will first be conducted, during which clear and appropriate information about the study will be provided to the patient. This will be followed by an inclusion medical visit, during which written informed consent will be obtained, randomization will be performed, and clinical data as well as routine care data and additional data specific to the PCRetro study will be collected. Patients will then undergo rehabilitation either in the control group, receiving usual care in a geriatric day hospital, or in the intervention group, in which two backward walking activities per week will be integrated over a 5 week period in the usual care. Follow-up medical visits will be scheduled at week 5 and at month 6, during which routine care and additional PCRetro study data will again be collected. The occurrence of falls and intercurrent events will be monitored over 12 months through monthly telephone calls made by a clinical research technician. For 10 patients in the intervention group, a semi-structured interview will also be conducted during the week 5 visit. 2 focus groups will be held with 2 randomly selected centers to identify barriers and facilitators to the implementation of backward walking sessions.

Expected benefits: The primary anticipated benefit is a long-term reduction in the incidence of falls. In the short term, neuromuscular and postural improvements are expected, including increased lower limb muscle strength and better static and dynamic balance, which may translate into higher gait speed, improved functional mobility, and possibly reduced fear of falling. In the medium term, a potential decrease in hospitalization and mortality rates is anticipated. In the long term, these benefits could have a significant positive impact on the quality of life of patients and their caregivers.

Expected risks: No serious adverse events have been reported in studies of backward walking to date. Rare cases of increased joint pain, muscle soreness, and heightened fatigue have been described.

Statistical analysis: It will be conducted under the intention-to-treat principle, with data described and stratified by trial arm using appropriate descriptive statistics. The primary outcome will be analyzed using a Poisson model, with prespecified sensitivity analyses, including adjusted and per-protocol analyses based on a priori defined confounders identified via a Directed Acyclic Graph. Binary secondary outcomes will be summarized as odds ratios with 95% confidence intervals, while continuous secondary outcomes will be analyzed using parametric or non-parametric tests as appropriate. Time-to-event endpoints will be examined using Kaplan-Meier curves and Cox proportional hazards models, with results expressed as hazard ratios and 95% confidence intervals. Missing data will be handled in line with current recommendations and the predefined estimand framework. Qualitative data from focus groups and semi-structured interviews will be analyzed independently by two researchers using a Grounded Theory-inspired approach and interpreted within the Normalization Process Theory framework.

Being tested
Walking backwards, Usual walking
Keywords
Fall, Geriatrics, Walking backwards

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Walking backwardsOther

    Standard care combined with rehabilitation sessions involving walking backwards. Ten rehabilitation sessions involving walking backwards are scheduled, at a rate of two sessions per week for five weeks, on a secure treadmill designed for walking backwards. Walking backwards will not add to the rehabilitation time; it will replace standard care to allow for two 10-minute sessions of actual walking backwards per week. Walking backwards are integrated to the 12 weeks standard program.

  • Usual walkingOther

    The standard program runs for 12 weeks, with sessions twice a week, comprising two 45-minute activities per day. At least one session per week must include balance training, muscle strengthening and multi-modal exercises. The treadmill may be used for these activities, but only for walking forwards.

Study groups in NCT07650097
Study groupRoleWhat they receive
Walking backwardsExperimentalNot described
Receives: Other: Walking backwards
Usual walkingActive comparatorNot described
Receives: Other: Usual walking

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of falls per patient between inclusion and one year of follow-up including rehabilitation period in a geriatric day hospital

    Number of falls per patient

    Measured: 12 months after inclusion

Secondary outcomes (15)
  1. Balance assessment

    Balance assessed using the Berg Scale. The Berg balance scale ranges from 0 to 56, with higher scores indicating better balance and a better outcome.

    Measured: At inclusion, Week 5 and 6 months

  2. Assessment of walking speed

    Walking speed assessed using the 4-metre walk test

    Measured: At inclusion, Week 5 and 6 months

  3. Measuring fear of falling

    Fear of falling measured using the Short Falls Efficacy Scale International (Short-FES-I). The Short-FES-I) ranges from 7 to 28 points, with higher scores indicating greater fear of falling and a worse outcome.

    Measured: At inclusion, Week 5 and 6 months

  4. Assessment of functional mobility

    Functional mobility assessed using the Time-up and Go test

    Measured: At inclusion, Week 5 and 6 months

  5. Time to first fall in days

    Telephone follow-up of the patient by a clinical research technician

    Measured: From inclusion to 12 months (monthly)

  6. Hospitalisation for any cause and due to a fall

    Telephone follow-up of the patient by a clinical research technician

    Measured: From inclusion to 12 mois (monthly)

  7. Vital status

    Telephone follow-up of the patient by a clinical research technician

    Measured: From inclusion to 12 months (monthly)

  8. Quality of life score

    Quality of life score will be assessed by the scale EuroQol - 5 Dimensions - 5 Levels (EQ-5D-5L scale). The EQ-5D-5L descriptive system consists of 5 dimensions (mobility, self-care, usual activities, pain/discomfort, anxiety/depression), each with 5 levels coded from 1 to 5. This yields a 5-digit health state code ranging from 11111 (no problems in any dimension) to 55555 (extreme problems in all dimensions). Each 5 digit health state is then converted into a utility index value ranging from values below 0 up to 1.00. For the index value, higher score indicates better health-related quality of life and a better outcome.

    Measured: At inclusion, Week 5 and 6 months

  9. Assessment of independence

    Independence measured using the Activities of Daily Living (ADL) scale. The ADL scale ranges from 0 to 6 points, with higher scores indicating greater independence in basic daily activities and a better outcome.

    Measured: At inclusion, Week 5 and 6 months

  10. Assessment of independence

    Independence measured using the Instrumental Activities of Daily Living (iADL) scale. The iADL scale ranges from 0 to 8 points, with higher scores indicating greater independence in complex daily activities and a better outcome.

    Measured: At inclusion, Week 5 and 6 months

  11. Assessment of user feedback

    User feedback measured using the French System Usability Scale (F-SUS) questionnaire (for the intervention arm only). The F-SUS is the validated French translation of the System Usability Scale. It consists of 10 items rated from 1 (strongly disagree) to 5 (strongly agree). F-SUS total scores yield a 0-100 usability score. For items 1, 3, 5, 7, and 9, subtract 1 from the user's rating; for items 2, 4, 6, 8, and 10, compute 5 minus the rating. Sum these 10 adjusted values and multiply the total by 2.5 to obtain the overall F-SUS score. F-SUS = 0 is worst usability, 100 is best usability.

    Measured: At Week 5

  12. Intercurrent events

    Intercurrent events at home and any incidents, including the number of patients wishing to stop the sessions or withdraw from the trial during each session, measured at each session by a doctor or physiotherapist

    Measured: At Week 1, Week 2, Week 3, Week 4, Week 5

  13. Completion of 80% of sessions by at least 80% of enrolled patients

    Measurement taken during a consultation by a doctor

    Measured: At Week 5

  14. Assessment of satisfaction and acceptability of backward walking

    Satisfaction and acceptability of backward walking assessed through 10 semi-structured individual interviews with included patients (intervention arm)

    Measured: No later than 1 month after Week 5

  15. Barriers and facilitators to the implementation of backward walking sessions

    Barriers and facilitators to the implementation of backward walking sessions identified during 2 focus groups with teams (doctors, nurses, physiotherapists, adapted physical activity (APA) professionals, occupational therapists and psychomotor therapists)

    Measured: No later than 1 month after the end of follow-up for the last patient included

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Jun 2026
  2. Study start15 Nov 2026 (estimated)
  3. Primary completion15 May 2029 (estimated)
  4. Study completion15 May 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
300 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07650097
Sponsor's protocol ID
APHP251245
Other IDs
2025-A02896-43
Acronym
PCRetro
Status last verified
Aug 2026
First submitted
10 Jun 2026
Last updated
31 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The procedures carried out with the French data privacy authority (CNIL, Commission nationale de l'informatique et des libertés) do not provide for the transmission of the database, nor do the information and consent documents signed by the patients. Consultation by the editorial board or interested researchers of individual participant data that underlie the results reported in the article after deidentification may nevertheless be considered, subject to prior determination of the terms and conditions of such consultation and in respect for compliance with the applicable regulations.

Questions about this trial

What is this clinical trial studying?

A study testing Walking backwards and Usual walking in people with High Risk of Falling, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 12 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 31 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Bruno OQUENDO, Dr (01 49 59 43 53, bruno.oquendo@aphp.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of falls per patient between inclusion and one year of follow-up including rehabilitation period in a geriatric day hospital (time frame: 12 months after inclusion). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in